Pictet Asset Management (Switzerland)’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
DTC
PAI
Pictet Asset Management (Switzerland)'s INSM Position: Q2 2023 in Review
Pictet Asset Management (Switzerland) reduced its Insmed (INSM) stake by 6% in Q2 2023, selling an estimated $4.45M and leaving 3,696,315 shares worth $78M. The position accounts for 0.09% of the portfolio, ranked #227.
Pictet Asset Management (Switzerland) first reported a position in INSM in Q3 2021 and has held it in 8 quarters since. The position peaked at $83.6M in Q1 2022. 223 funds tracked by Wall St. Rank hold INSM as of Q2 2023.
- Pictet Asset Management (Switzerland) held 3,696,315 shares of Insmed worth $78M as of Q2 2023.
- Pictet Asset Management (Switzerland) sold 234,448 Insmed shares in Q2 2023, an estimated $4.45M.
- Insmed made up 0.09% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #227 holding.
- Pictet Asset Management (Switzerland) first reported a position in Insmed in Q3 2021 and has held it in 8 quarters since.
- Pictet Asset Management (Switzerland)'s Insmed position peaked at $83.6M in Q1 2022.
- 223 funds tracked by Wall St. Rank held Insmed as of Q2 2023.
Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.